Roivant Sciences
(NASDAQ:ROIV)
$10.54
0.18[1.74%]
At close: Apr 19
$10.54
0[0.00%]
After Hours: 4:57PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
75%
Overview Rating
Good
Technicals Analysis
66
0100
Financials Analysis
80
0100

Roivant Sciences Stock (NASDAQ:ROIV), Quotes and News Summary

Roivant Sciences Stock (NASDAQ: ROIV) stock price, news, charts, stock research, profile.

Open$10.300
Close$10.460
Volume / Avg.4.664M / 7.325M
Day Range10.265 - 10.480
52 Wk Range8.060 - 13.240
Market Cap$8.494B
P/E Ratio1.968
Dividend Yield-
ExchangeNASDAQ
RSI
45
Short Interest
7.2%
Days to Cover2.21

Recent News

Vivek Ramaswamy-Founded Roivant's Anti-Inflammatory Drug Aces Mid-Stage Study
Roivant Sciences and Priovant Therapeutics report Phase 2 results for brepocitinib in treating non-anterior non-infectious uveitis. Week 24 data show promising efficacy, with lower treatment failure rates and positive secondary endpoints. Roivant authorizes a $1.5 billion share repurchase program
Vandana Singh
Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations
Wednesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topical "soft" JAK 1/3 inhibitor, in patients with mild to 
Vandana Singh
Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50%
Immunovant Inc (NASDAQ: IMVT), on Thursday, released the results from the initial cohort of patients in an ongoing 24-week Phase 2 trial of batoclimab in 
Vandana Singh
80%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
1
Jan
2
Feb
1
Mar
3
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Roivant Sciences Ltd
Sector
Health Care
Industry
Biotechnology
Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcar...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ROIV
LEGN

FAQ

Q

How do I buy Roivant Sciences (ROIV) stock?

A

You can purchase shares of Roivant Sciences (NASDAQ: ROIV) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Roivant Sciences's (ROIV) competitors?

A

Other companies in Roivant Sciences’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

Q

What is the target price for Roivant Sciences (ROIV) stock?

A

The latest price target for Roivant Sciences (NASDAQ: ROIV) was reported by Goldman Sachs on Wednesday, April 3, 2024. The analyst firm set a price target for 18.00 expecting ROIV to rise to within 12 months (a possible 70.78% upside). 28 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Roivant Sciences (ROIV)?

A

The stock price for Roivant Sciences (NASDAQ: ROIV) is $10.54 last updated Today at April 19, 2024 at 4:57 PM EDT.

Q

Does Roivant Sciences (ROIV) pay a dividend?

A

There are no upcoming dividends for Roivant Sciences.

Q

When is Roivant Sciences (NASDAQ:ROIV) reporting earnings?

A

Roivant Sciences’s Q4 earnings are confirmed for Wednesday, June 26, 2024.

Q

Is Roivant Sciences (ROIV) going to split?

A

There is no upcoming split for Roivant Sciences.

Q

What sector and industry does Roivant Sciences (ROIV) operate in?

A

Roivant Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch